1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Artificial Tears Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Artificial Tears Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing prevalence of dry eye is expected to drive the artificial tears market
5.2 Market Opportunities
- 5.2.1 Launch of the novel product has helped the company retain its position in the eye drop industry, such strategic events are likely to offer lucrative opportunity for the artificial tears market during the forecast period.
5.3 Future Trends
- 5.3.1 Change in lifestyle would eventually damage the eye health, generating a greater demand for artificial tear drops during the forecast period.
5.4 Impact of Drivers and Restraints
6. North America Artificial Tears Market Regional Analysis
6.1 North America Artificial Tears Market Overview
6.2 North America Artificial Tears Market Revenue 2019-2028 (US$ Million)
6.3 North America Artificial Tears Market Forecast Analysis
7. North America Artificial Tears Market Analysis – by Type
7.1 Cellulose Derived Tears
- 7.1.1 Overview
- 7.1.2 Cellulose Derived Tears: North America Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Glycerin Derived Tears
- 7.2.1 Overview
- 7.2.2 Glycerin Derived Tears: North America Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Oil-based Emulsion Tears
- 7.3.1 Overview
- 7.3.2 Oil-based Emulsion Tears: North America Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Polythylene Glycol Based Tears
- 7.4.1 Overview
- 7.4.2 Polythylene Glycol Based Tears: North America Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Propylene Glycol Based Tears
- 7.5.1 Overview
- 7.5.2 Propylene Glycol Based Tears: North America Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Sodium Hyaluronate Based Artificial Tears
- 7.6.1 Overview
- 7.6.2 Sodium Hyaluronate Based Artificial Tears: North America Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Artificial Tears Market Analysis – by Delivery Mode
8.1 Eye Drops
- 8.1.1 Overview
- 8.1.2 Eye Drops: North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Ointments
- 8.2.1 Overview
- 8.2.2 Ointments: North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Artificial Tears Market Analysis – by Application
9.1 Dry Eyes Treatment
- 9.1.1 Overview
- 9.1.2 Ointments: North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Contact Lenses Moisture
- 9.2.1 Overview
- 9.2.2 Ointments: North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Artificial Tears Market – North America Analysis
10.1 North America
- 10.1.1 North America Artificial Tears Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Artificial Tears Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Artificial Tears Market Breakdown, by Type
- 10.1.1.1.2 US: North America Artificial Tears Market Breakdown, by Delivery Mode
- 10.1.1.1.3 US: North America Artificial Tears Market Breakdown, by Application
- 10.1.1.2 Canada:
North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Artificial Tears Market Breakdown, by Type
- 10.1.1.2.2 Canada: North America Artificial Tears Market Breakdown, by Delivery Mode
- 10.1.1.2.3 Canada: North America Artificial Tears Market Breakdown, by Application
- 10.1.1.3 Mexico :
North America Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Artificial Tears Market Breakdown, by Type
- 10.1.1.3.2 Mexico : North America Artificial Tears Market Breakdown, by Delivery Mode
- 10.1.1.3.3 Mexico : North America Artificial Tears Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Artificial Tears Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Johnson and Johnson Services, Inc.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Alcon Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 OASIS Medical
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 AbbVie Inc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Bayer AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Prestige Consumer Healthcare Inc.
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Santen Pharmaceutical Co., Ltd.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Bausch Health Companies Inc.
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Akorn, Incorporated
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights